Dimensional Fund Advisors LP Kamada LTD Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.22 - $5.85 $290,711 - $403,000	-68,889 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.43 - $6.81 $91,690 - $114,993	16,886 Added 32.47%	68,889 $380,000
Q4 2021 Feb 09, 2022	BUY	$5.21 - $6.82 $22,663 - $29,667	4,350 Added 9.13%	52,003 $342,000
Q2 2021 Aug 12, 2021	SELL	$5.67 - $6.33 $9,786 - $10,925	-1,726 Reduced 3.5%	47,653 $277,000
Q1 2021 May 14, 2021	SELL	$6.02 - $8.06 $35,072 - $46,957	-5,826 Reduced 10.55%	49,379 $306,000
Q4 2020 Feb 25, 2021	BUY	$6.3 - $8.46 $347,791 - $467,034	55,205 New	55,205 $358,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $260M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.